GCP
PRVL

GSA Capital Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

GSA Capital Partners’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,717
Closed -$824K – 1666
2020
Q4 		$824K Sell
35,717
-17,301
-33% -$399K 0.13% 189
2020
Q3 		$540K Buy
+53,018
New +$540K 0.09% 346